Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC; 4-T Study Group.

N Engl J Med. 2007 Oct 25;357(17):1716-30. Epub 2007 Sep 21.

PMID:
17890232
[PubMed - indexed for MEDLINE]
Free Article
2.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Ilag LL, Kerr L, Malone JK, Tan MH.

Clin Ther. 2007 Jun;29(6 Pt 1):1254-70. Review.

PMID:
18036388
[PubMed - indexed for MEDLINE]
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
4.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
[PubMed - indexed for MEDLINE]
5.

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

Clin Ther. 2005;27 Suppl B:S75-88. Review.

PMID:
16519039
[PubMed - indexed for MEDLINE]
6.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Ilag LL, Kerr L, Malone JK, Tan MH.

Clin Ther. 2007;29 Spec No:1254-70. Review.

PMID:
18046926
[PubMed - indexed for MEDLINE]
7.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
[PubMed - indexed for MEDLINE]
8.

Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.

Liu SC, Tu YK, Chien MN, Chien KL.

Diabetes Obes Metab. 2012 Sep;14(9):810-20. doi: 10.1111/j.1463-1326.2012.01606.x. Epub 2012 Apr 29. Review.

PMID:
22486990
[PubMed - indexed for MEDLINE]
9.

Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature.

Balena R, Hensley IE, Miller S, Barnett AH.

Diabetes Obes Metab. 2013 Jun;15(6):485-502. doi: 10.1111/dom.12025. Epub 2012 Nov 12. Review.

PMID:
23061470
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.

Shanik MH.

Diabetes Technol Ther. 2012 Jun;14(6):533-9. doi: 10.1089/dia.2011.0256. Epub 2012 Feb 24. Review.

PMID:
22364142
[PubMed - indexed for MEDLINE]
11.

Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review.

Giugliano D, Maiorino MI, Bellastella G, Chiodini P, Esposito K.

J Diabetes Complications. 2011 Jul-Aug;25(4):275-81. doi: 10.1016/j.jdiacomp.2011.03.005. Epub 2011 May 20. Review.

PMID:
21601479
[PubMed - indexed for MEDLINE]
12.

What options are available when considering starting insulin: premix or basal?

Lavernia F.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S85-92. doi: 10.1089/dia.2010.0248. Review. Erratum in: Diabetes Technol Ther. 2011 Sep;13(9):980.

PMID:
21668341
[PubMed - indexed for MEDLINE]
13.

Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes.

Raja-Khan N, Warehime SS, Gabbay RA.

Vasc Health Risk Manag. 2007;3(6):919-35. Review.

PMID:
18200811
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Stepwise intensification of insulin therapy in type 2 diabetes management--exploring the concept of the basal-plus approach in clinical practice.

Owens DR.

Diabet Med. 2013 Mar;30(3):276-88. doi: 10.1111/dme.12019. Review.

PMID:
22998363
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Can glycemic targets be achieved-- in particular with two daily injections of a mix of intermediate- and short-acting insulin?

Raskin P.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:52-4. Review.

PMID:
16627381
[PubMed - indexed for MEDLINE]
16.

Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: a systematic review.

Giugliano D, Maiorino MI, Bellastella G, Chiodini P, Esposito K.

Diabetes Res Clin Pract. 2011 Apr;92(1):1-10. doi: 10.1016/j.diabres.2010.08.006. Epub 2010 Sep 6. Review.

PMID:
20822821
[PubMed - indexed for MEDLINE]
17.

Glimepiride: evidence-based facts, trends, and observations (GIFTS). [corrected].

Basit A, Riaz M, Fawwad A.

Vasc Health Risk Manag. 2012;8:463-72. doi: 10.2147/HIV.S33194. Epub 2012 Aug 15. Review. Erratum in: Vasc Health Risk Manag. 2013;9:1.

PMID:
23028231
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Insulin analogs and glycosylated hemoglobin target of less than 7% in type 2 diabetes: a systematic review of randomized trials.

Esposito K, Maiorino MI, Bellastella G, Chiodini P, Giugliano D.

Metab Syndr Relat Disord. 2011 Jun;9(3):167-76. doi: 10.1089/met.2010.0134. Epub 2011 Mar 16. Review.

PMID:
21410335
[PubMed - indexed for MEDLINE]
19.

Basal plus basal-bolus approach in type 2 diabetes.

Ampudia-Blasco FJ, Rossetti P, Ascaso JF.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S75-83. doi: 10.1089/dia.2011.0001. Review.

PMID:
21668340
[PubMed - indexed for MEDLINE]
20.

Insulin analog therapy: improving the match with physiologic insulin secretion.

Freeman JS.

J Am Osteopath Assoc. 2009 Jan;109(1):26-36. Review.

PMID:
19193822
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk